Trials of the British Army's Ajax armoured vehicle will be "proceeding cautiously" after they were halted last year, a defence minister has said. A decision was made to stop using the Ajax after ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

Eli Lilly LLY0.87%increase; green up pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...

April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up ‌to $2.3 billion in cash, as the U.S. drugmaker looks to ...

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax Therapeutics for its clinical-stage myelofibrosis therapy. At the center of the deal ...

FC Bayern Munich are monitoring Ajax Amsterdam winger Mika Godts as they seek to bolster their attack. Ajax are preparing an ambitious swoop for Real Madrid midfielder Dani Ceballos this summer. Led ...

Everything you need to know about how to watch Ajax in the Eredivisie and all major competitions. A team with a lot of legacy, Ajax have a huge fan base in the USA. Hence, GOAL brings to you all the ...

Wednesday 16° 6° Considerable cloudiness. Highs 15 to 17C and lows 5 to 7C. Thursday 12° 6° Plenty of sun. Highs 11 to 13C and lows 5 to 7C. Friday 15° 10° Mix of sun and clouds. Highs 14 to 16C and ...

Mary Hall is a editor for Investopedia's Advisor Insights, in addition to being the editor of several books and doctoral papers. Mary received her bachelor's in English from Kent State University with ...

Of Lilly’s six M&A deals so far in 2026, half have been oncology focused. Credit: Jennie Book/Shutterstock.com. Eli Lilly has added yet another string to its M&A bow of 2026 after agreeing to acquire ...

Eli Lilly is picking up Ajax Therapeutics and its once-daily oral blood cancer candidate. The deal follows the pharma’s buyouts of ADC specialist CrossBridge Bio and in vivo CAR T company Kelonia ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.